CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses

被引:128
|
作者
Lineburg, Katie E. [1 ,2 ]
Grant, Emma J. [3 ,4 ]
Swaminathan, Srividhya [1 ,2 ,5 ]
Chatzileontiadou, Demetra S. M. [3 ,4 ]
Szeto, Christopher [3 ,4 ]
Sloane, Hannah [3 ,4 ]
Panikkar, Archana [1 ,2 ]
Raju, Jyothy [1 ,2 ]
Crooks, Pauline [1 ,2 ]
Rehan, Sweera [1 ,2 ]
Nguyen, Andrea T. [3 ,4 ]
Lekieffre, Lea [1 ,2 ]
Neller, Michelle A. [1 ,2 ]
Tong, Zhen Wei Marcus [6 ]
Jayasinghe, Dhilshan [3 ,4 ]
Chew, Keng Yih [6 ]
Lobos, Christian A. [3 ,4 ]
Halim, Hanim [3 ]
Burrows, Jacqueline M. [1 ,2 ]
Riboldi-Tunnicliffe, Alan [7 ]
Chen, Weisan [4 ]
D'Orsogna, Lloyd [8 ,9 ]
Khanna, Rajiv [1 ,2 ]
Short, Kirsty R. [6 ,10 ]
Smith, Corey [1 ,2 ,5 ]
Gras, Stephanie [3 ,4 ]
机构
[1] QIMR Berghofer Med Res Inst, QIMR Berghofer Ctr Immunotherapy & Vaccine Dev, Dept Immunol, Brisbane, Qld 4006, Australia
[2] QIMR Berghofer Med Res Inst, Translat & Human Immunol Lab, Dept Immunol, Brisbane, Qld 4006, Australia
[3] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia
[4] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic 3086, Australia
[5] Univ Queensland, Fac Med, Brisbane, Qld 4072, Australia
[6] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia
[7] ANSTO, Australian Synchrotron, Clayton, Vic 3168, Australia
[8] Fiona Stanley Hosp, Dept Clin Immunol, PathWest Lab Med, Murdoch, WA 6150, Australia
[9] Univ Western Australia, Sch Med, Nedlands, WA 6009, Australia
[10] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia
基金
英国医学研究理事会; 澳大利亚研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
COVID-19; IMMUNITY; ESCAPE; IMPACT; TCR;
D O I
10.1016/j.immuni.2021.04.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Efforts are beingmade worldwide to understand the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease 2019 (COVID-19) pandemic, including the impact of T cell immunity and cross-recognition with seasonal coronaviruses. Screening of SARS-CoV-2 peptide pools revealed that the nucleocapsid (N) protein induced an immunodominant response in HLA-B7(+) COVID-19-recovered individuals that was also detectable in unexposed donors. A single N-encoded epitope that was highly conserved across circulating coronaviruses drove this immunodominant response. In vitro peptide stimulation and crystal structure analyses revealed T cell-mediated cross-reactivity toward circulating OC43 and HKU-1 betacoronaviruses but not 229E or NL63 alphacoronaviruses because of different peptide conformations. T cell receptor (TCR) sequencing indicated that cross-reactivity was driven by private TCR repertoires with a bias for TRBV27 and a long CDR3b loop. Our findings demonstrate the basis of selective T cell cross-reactivity for an immunodominant SARS-CoV-2 epitope and its homologs from seasonal coronaviruses, suggesting long-lasting protective immunity.
引用
收藏
页码:1055 / +
页数:16
相关论文
共 50 条
  • [1] Antibodies to Seasonal Coronaviruses Rarely Cross-React With SARS-CoV-2 Findings From an African Birth Cohort
    Zar, Heather J.
    Nicol, Mark P.
    MacGinty, Rae
    Workman, Lesley
    Petersen, Wonita
    Johnson, Marina
    Goldblatt, David
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2021, 40 (12) : E516 - E519
  • [2] Identification of cross-reactive CD8+ T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variants
    Hu, Chao
    Shen, Meiying
    Han, Xiaojian
    Chen, Qian
    Li, Luo
    Chen, Siyin
    Zhang, Jing
    Gao, Fengxia
    Wang, Wang
    Wang, Yingming
    Li, Tingting
    Li, Shenglong
    Huang, Jingjing
    Wang, Jianwei
    Zhu, Ju
    Chen, Dan
    Wu, Qingchen
    Tao, Kun
    Pang, Da
    Jin, Aishun
    GENES & DISEASES, 2022, 9 (01) : 216 - 229
  • [3] Dissecting the Protective Effect of CD8+ T Cells in Response to SARS-CoV-2 mRNA Vaccination and the Potential Link with Lymph Node CD8+ T Cells
    Chen, Mengfei
    Venturi, Vanessa
    Munier, C. Mee Ling
    BIOLOGY-BASEL, 2023, 12 (07):
  • [4] Antibodies Against SARS-CoV-2 Do Not Cross-React with Endemic Coronaviruses in a Pediatric Population: Data from a Bangladesh Cohort
    Marquez, Ana Citlali
    Tanunliong, Guadalein
    Kabir, Mamun
    Alam, Masud
    Hossain, Biplob
    Rashid, Humaira
    Jassem, Agatha N.
    Sekirov, Inna
    Haque, Rashidul
    Morshed, Muhammad
    VIRUSES-BASEL, 2025, 17 (02):
  • [5] Human CD4+ T cells specific for dominant epitopes of SARS-CoV-2 Spike and Nucleocapsid proteins with therapeutic potential
    Verhagen, Johan
    van Der Meijden, Edith D.
    Lang, Vanessa
    Kremer, Andreas E.
    Voelkl, Simon
    Mackensen, Andreas
    Aigner, Michael
    Kremer, Anita N.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2021, 205 (03) : 363 - 378
  • [6] T cell receptor usage and epitope specificity amongst CD8+ and CD4+ SARS-CoV-2-specific T cells
    Fahnoe, Ulrik
    Feng, Shan
    Underwood, Alexander P.
    Jacobsen, Kivin
    Ameri, Amir
    Blicher, Thomas H.
    Solund, Christina S.
    Rosenberg, Brad R.
    Brix, Liselotte
    Weis, Nina
    Bukh, Jens
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [7] A novel method for identifying SARS-CoV-2 infection mutants via an epitope-specific CD8+ T cell test
    Qiu, Congling
    Peng, Bo
    Xiao, Chanchan
    Chen, Pengfei
    Mao, Lipeng
    Shi, Xiaolu
    Zhang, Zhen
    Lv, Ziquan
    Lv, Qiuying
    Zhang, Xiaomin
    Li, Jiaxin
    Huang, Yanhao
    Hu, Qinghua
    Chen, Guobing
    Zou, Xuan
    Liang, Xiaofeng
    BIOSAFETY AND HEALTH, 2024, 6 (03) : 143 - 152
  • [8] Surveillance of SARS-CoV-2 immunogenicity: loss of immunodominant HLA-A*02-restricted epitopes that activate CD8+ T cells
    Lopes-Ribeiro, Agata
    Oliveira, Patricia de Melo
    Retes, Henrique Morais
    Barbosa-Stancioli, Edel Figueiredo
    da Fonseca, Flavio Guimaraes
    Tsuji, Moriya
    Coelho-dos-Reis, Jordana Grazziela Alves
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [9] Dominant CD8+ T Cell Nucleocapsid Targeting in SARS-CoV-2 Infection and Broad Spike Targeting From Vaccination
    Taus, Ellie
    Hofmann, Christian
    Ibarrondo, Francisco Javier
    Hausner, Mary Ann
    Fulcher, Jennifer A.
    Krogstad, Paul
    Ferbas, Kathie G.
    Tobin, Nicole H.
    Rimoin, Anne W.
    Aldrovandi, Grace M.
    Yang, Otto O.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [10] CD8+ T Cells in SARS-CoV-2 Induced Disease and Cancer-Clinical Perspectives
    Mortezaee, Keywan
    Majidpoor, Jamal
    FRONTIERS IN IMMUNOLOGY, 2022, 13